| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |